Total Payments
$34,908
2024 Payments
$461.60
Companies
19
Transactions
69
Payment Breakdown by Category
Research$33,902 (97.1%)
Food & Beverage$1,006 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $33,902 | 10 | 97.1% |
| Food and Beverage | $1,006 | 59 | 2.9% |
Payments by Type
Research
$33,902
10 transactions
General
$1,006
59 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $31,648 | 9 | $0 (2024) |
| Allergan Inc. | $2,254 | 1 | $0 (2019) |
| Cranial Technologies, Inc | $151.47 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $140.94 | 9 | $0 (2024) |
| PFIZER INC. | $115.19 | 8 | $0 (2023) |
| Sobi, Inc | $115.01 | 4 | $0 (2022) |
| Tris Pharma Inc | $88.44 | 7 | $0 (2019) |
| Shire North American Group Inc | $74.11 | 4 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $66.02 | 3 | $0 (2024) |
| Verrica Pharmaceuticals Inc. | $60.64 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $461.60 | 12 | Eli Lilly and Company ($262.77) |
| 2023 | $709.63 | 8 | Eli Lilly and Company ($594.36) |
| 2022 | $30,461 | 6 | Eli Lilly and Company ($30,412) |
| 2021 | $378.74 | 2 | Eli Lilly and Company ($378.74) |
| 2020 | $32.29 | 2 | Ironshore Pharmaceuticals Inc. ($16.72) |
| 2019 | $2,460 | 11 | Allergan Inc. ($2,254) |
| 2018 | $166.35 | 12 | PFIZER INC. ($59.46) |
| 2017 | $238.82 | 16 | Shire North American Group Inc ($74.11) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $19.01 | General |
| Category: Cranial Orthotic | ||||||
| 11/22/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/31/2024 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $23.26 | General |
| 10/07/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9, VAXELIS | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: VACCINE | ||||||
| 09/25/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/30/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Cranial Orthotic | ||||||
| 08/05/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: DERMATOLOGY | ||||||
| 04/27/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: DERMATOLOGY | ||||||
| 02/03/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: DERMATOLOGY | ||||||
| 01/29/2024 | Eli Lilly and Company | — | — | In-kind items and services | $206.83 | Research |
| Study: A PHASE 3, 12 MONTH, OPEN LABEL STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE PIONEER PEDS2 | ||||||
| 01/23/2024 | Eli Lilly and Company | — | — | In-kind items and services | $55.94 | Research |
| Study: PEDIATRIC OPTIONS FOR MIGRAINE RELIEF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF LASMIDITAN FOR ACUTE TREATMENT OF MIGRAINE PIONEER PEDS1 | ||||||
| 11/20/2023 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $11.33 | General |
| Category: Cranial Orthotic | ||||||
| 10/25/2023 | SANOFI PASTEUR INC. | BEYFORTUS (Biological), MENQUADFI | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Vaccines | ||||||
| 05/02/2023 | Merck Sharp & Dohme LLC | M-M-R II (Biological), GARDASIL 9, VAXELIS | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: VACCINE | ||||||
| 04/27/2023 | SANOFI PASTEUR INC. | MENQUADFI (Biological), VAXELIS | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Vaccines | ||||||
| 04/12/2023 | PFIZER INC. | PREVNAR 13 (Biological), TRUMENBA, COMIRNATY | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: VACCINES | ||||||
| 03/18/2023 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $15.27 | General |
| Category: Cranial Orthotic | ||||||
| 02/08/2023 | Hologic Sales and Service, LLC | THINPREP 2000 PROCESSOR (Device), APTIMA | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Diagnostics | ||||||
| 01/31/2023 | Eli Lilly and Company | — | — | In-kind items and services | $594.36 | Research |
| Study: PEDIATRIC OPTIONS FOR MIGRAINE RELIEF A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY OF LASMIDITAN FOR ACUTE TREATMENT OF MIGRAINE PIONEER PEDS1 | ||||||
| 11/15/2022 | Eli Lilly and Company | — | — | Cash or cash equivalent | $2,501.00 | Research |
| Study: A PHASE 3, 12 MONTH, OPEN LABEL STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE PIONEER PEDS2 | ||||||
| 09/27/2022 | Eli Lilly and Company | — | — | Cash or cash equivalent | $24,914.00 | Research |
| Study: PEDIATRIC OPTIONS FOR MIGRAINE RELIEF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF LASMIDITAN FOR ACUTE TREATMENT OF MIGRAINE PIONEER PEDS1 | ||||||
| 08/28/2022 | Eli Lilly and Company | — | — | In-kind items and services | $1,187.00 | Research |
| Study: A PHASE 3, 12 MONTH, OPEN LABEL STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE PIONEER PEDS2 | ||||||
| 08/24/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), VAXELIS, VAXNEUVANCE | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: VACCINE | ||||||
| 07/07/2022 | Sobi, Inc | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $30.87 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PEDIATRIC OPTIONS FOR MIGRAINE RELIEF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF LASMIDITAN FOR ACUTE TREATMENT OF MIGRAINE PIONEER PEDS1 | Eli Lilly and Company | $26,914 | 4 |
| A PHASE 3, 12 MONTH, OPEN LABEL STUDY OF LASMIDITAN IN PEDIATRIC PATIENTS WITH MIGRAINE PIONEER PEDS2 | Eli Lilly and Company | $4,139 | 4 |
| Clinical Trial LIN-MD-64 Ped FC Trial 6-17 Ph3 | Allergan Inc. | $2,254 | 1 |
| PEDIATRIC OPTIONS FOR MIGRAINE RELIEF A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY OF LASMIDITAN FOR ACUTE TREATMENT OF MIGRAINE PIONEER PEDS1 | Eli Lilly and Company | $594.36 | 1 |
About Dr. Doris Diaz, MD
Dr. Doris Diaz, MD is a Pediatrics healthcare provider based in Miami Lakes, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1932355138.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Doris Diaz, MD has received a total of $34,908 in payments from pharmaceutical and medical device companies, with $461.60 received in 2024. These payments were reported across 69 transactions from 19 companies. The most common payment nature is "" ($33,902).
Ad
Practice Information
- Specialty Pediatrics
- Location Miami Lakes, FL
- Active Since 08/07/2008
- Last Updated 10/09/2019
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1932355138
Products in Payments
- LINZESS (Drug) $2,254
- Doc Band (Device) $151.47
- Synagis (Drug) $84.14
- VYVANSE (Drug) $74.11
- Dyanavel XR (Drug) $61.66
- YCANTH (Drug) $60.64
- ROTATEQ (Biological) $59.67
- EUCRISA (Drug) $55.17
- TZIELD (Biological) $42.76
- SYNAGIS (Drug) $30.87
- PREVNAR - 13 (Biological) $28.25
- Quillivant XR (Drug) $26.78
- PREVNAR 13 (Biological) $20.16
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $19.10
- Oralair (Drug) $18.55
- GARDASIL (Biological) $18.22
- GARDASIL 9 (Biological) $18.07
- BEYFORTUS (Biological) $17.87
- THINPREP 2000 PROCESSOR (Device) $17.80
- GARDASIL9 (Biological) $16.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Miami Lakes
Lysette Iglesias, M.d, M.D
Pediatrics — Payments: $2,216
Pediatrics $2,216
Alexander Gomez, Md, MD
Pediatrics — Payments: $2,142
Pediatrics $2,142
Ruth Schobel, Md, MD
Pediatrics — Payments: $1,822
Pediatrics $1,822
Mayra Capote, Md, MD
Pediatrics — Payments: $1,590
Pediatrics $1,590
Merryl Dweck, M.d, M.D
Pediatrics — Payments: $1,082
Pediatrics $1,082
Enrique Dieguez, M.d, M.D
Pediatrics — Payments: $683.72
Pediatrics $683.72